Methohexital Sodium for Injection — Class II drug recall D-0662-2026
Ongoing recall by ONESOURCE SPECIALTY PHARMA LIMITED, reported 2026-07-15, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0662-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | ONESOURCE SPECIALTY PHARMA LIMITED, Bengaluru, N/A, India |
| Recall initiated | 2026-06-07 |
| Classified | 2026-07-07 |
| Reported by FDA | 2026-07-15 |
| Distributed | Nationwide (US) |
| Quantity | 4,284 vials |
| Reason classes | specification failure |
| NDC | 23155-0893, 23155-0893-31 |
| Lot numbers | 7000612A |
| Expiration dates | 2028-01 |
Product
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0662-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.